Philip Atherton
Professor of Clinical, metabolic & Molecular Physiology at the University of Nottingham.
I have been principal or co-investigator on successful project grants from UK research councils (MRC, BBSRC), the European Union (EUFP7), charities (Dunhill Medical Trust) and industrial (Ajinomoto, Abbott Nutrition, Fresenius-Kabi) sources to the tune of >£10 Million. Since 2005 (at PhD award) I have published ~150 peer-reviewed articles (H-index 56, i10 index 102, ~15,000 citations - Google Scholar) and 6 invited book chapters and my work has placed me in the world's top 5% of cited authors for work in Biology & Biochemistry (source: Thomson Reuters). I have received prestigious early career awards (e.g. American Physiological Society World New investigator 2010) and am regularly invited to speak at both national (e.g. Physiological Society) and international (e.g. EB, ECSS, ASPEN, ICAAP, A/ESPEN) conferences. Our group collaborates nationally and internationally. Our labs presently hosts 3 technicians, ~15 PhD non-clinical and clinical MRes/PhD students & 3 Research Fellows. Our lab is housed at the Royal Derby hospital postgraduate entry medical school under the auspices of a UK Medical Research Council/Arthritis Research UK Centre of excellence for musculoskeletal ageing research, and NIHR Biomedical Research Centre (BRC) under a musculoskeletal theme.
Visit website: https://www.nottingham.ac.uk/medicine/people/philip.atherton
See also: University of Nottingham - Public research university.
Details last updated 17-Apr-2021
Philip Atherton is also referenced in the following:
UK SPINE 2021 Annual conference
21-Apr-2021 to 23-Apr-2021
Series of events focused on research and innovation in geroscience and ageing therapeutics organized by UK SPINE.
Philip Atherton News
Insights from the 4th longevity investors conference - future health & longevity
Live Forever Club - 16-Oct-2023
The event's success fuels optimism for future longevity awareness events
Read more...